BMO Capital Markets Initiates Coverage on Sarepta Therapeutics (NASDAQ:SRPT) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Sigma Planning Corp lifted its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 2.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 12,405 shares of the biotechnology company’s stock after purchasing an additional 300 shares during the period. Sigma Planning Corp’s holdings in Sarepta Therapeutics […]
M&T Bank Corp increased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 13.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,582 shares of the biotechnology company’s stock after acquiring an additional 411 shares during the quarter. […]
Sarepta Therapeutics, Inc (NASDAQ:SRPT) Short Interest Update themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a report issued on Monday, Benzinga reports. They presently have a $140.00 price objective on the biotechnology company’s stock. Needham & Company LLC’s price target suggests a potential upside of 15.05% from the company’s previous close. […]